Congenital and acquired long QT syndrome

European Heart Journal

Volumn 21, Issue 15, 2000, Pages 1232-1237

  Camm, A J ^a   Janse, M J ^d   Roden, D M ^d   Rosen, M R ^d   Cinca, J ^b   Cobbe, S M ^c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

HEART FAILURE; HEART REPOLARIZATION; HEART VENTRICLE HYPERTROPHY; HUMAN; LONG QT SYNDROME; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW;

ACTION POTENTIALS; CATION TRANSPORT PROTEINS; DNA-BINDING PROTEINS; ELECTROCARDIOGRAPHY; ETHER-A-GO-GO POTASSIUM CHANNELS; HUMANS; KCNQ POTASSIUM CHANNELS; KCNQ1 POTASSIUM CHANNEL; LONG QT SYNDROME; MYOCARDIUM; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; TRANS-ACTIVATORS;

EID: 0033916119     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2222     Document Type: Review

References (50)

1. Priori SG, Barhanin J, Hauer RN. Genetic and molecular basis of cardiac arrhythmias; impact on clinical management. Study group on molecular basis of arrhythmias of the working group on arrhythmias of the European society of cardiology. Eur Heart J. 20:1999;174-195.
2. Roden DM. Taking the idio out of idiosyncratic - predicting torsades de pointes. PACE. 21:1998;1029-1034.
3. Day CP, McComb JM, Campbell RWF. QT dispersion: An indication of arrhythmia risk in patients with long QT intervals. Br Heart J. 63:1990;342-344.
4. Surawicz B. Electrophysiological substrate for Torsade de Pointes: dispersion of refractoriness or early after depolarizations. J Am Coll Cardiol. 14:1989;172-184.
5. Haverkamp W, Shenassa M, Borggrefe M, Breithardt G. Torsades de Pointes. Zipes DP, Jalife J. Cardiac electrophysiology: from cell to bedside. 1995;849-855 W.B. Saunders Company, Philadelphia.
6. Singh B. Amiodarone: pharmacological, electrophysiogical, and clinical profile of an unusual antiarrhythmic compound. Singh BN, Wellens HJJ, Hiraoka M. Electropharmacological control of cardiac arrhythmias. 1994;497-522 Futura Publishing Company, Mount Kisco.
7. Han J, Moe GK. Nonuniform recovery of excitability in ventricular muscle. Circ Res. 14:1964;44-60.
8. Janse MJ, Capucci A, Coronel R, Fabius MAW. Variability in recovery of excitability in the normal canine and the ischaemic porcine heart. Eur Heart J. 6:1985;41-50.
9. Anyukhovsky EP, Sosunov EA, Rosen MR. Regional differences in electrophysiological properties of epicardium, midmyocardium, and endocardium. Circulation. 94:1996;1981-1988.
10. Yan G-X, Antzelevitch A. Cellular basis for the normal T-wave and the electrocardiographic manifestations of the long QT-syndrome. Circulation. 98:1998;1928-1936.
11. Kuo C-S, Munakata K, Reddy CP, Surawicz B. Characteristics and possible mechanisms of ventricular arrhythmias dependent on dispersion of action potential durations. Circulation. 67:1983;1356-1367.
12. Opthof T, Ramdat Misier AR, Coronel R. Dispersion of refractoriness in canine ventricular muscle. Effects of sympathetic stimulation. Circ Res. 68:1991;1204-1215.
13. Ramdat Misier AR, Opthof T, Van Hemel NM. Increased dispersion of 'refractoriness' in patients with idiopathic paroxysmal atrial fibrillation. J Am Coll Cardiol. 19:1992;1531-1535.
14. Ramdat Misier AR, Opthof T, Van Hemel NM. Dispersion of 'refractoriness' in noninfarcted myocardium of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction. Circulation. 91:1995;2566-2572.
15. Sicouri S, Antzelevitch C. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of canine ventricle. The M cell. Circ Res. 68:1991;1729-1741.
16. Kscontributes to the longer action potential of the M cell. Circ Res. 76:1995;351-365.
17. Rodriguez-Sinovas A, Cinca J, Tapias A, Armadans L, Tresanchez M, Soler-Soler J. Lack of evidence of M cells in porcine left ventricular myocardium. Cardiovasc Res. 33:1997;307-313.
18. Drouin E, Charpentier F, Gauthier C, Laurent K, Le Marec H. Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells. J Am Coll Cardiol. 26:1995;185-192.
19. Shimizu W, Antzelevitch C. Cellular and ionic basis for T-wave alternans under long-QT conditions. Circulation. 99:1999;1499-1507.
20. Anyukhovsky EP, Sosunov EA, Gainullin RZ, Rosen MR. The controversial M cell. J Cardiovasc Electrophysiol. 10:1999;244-260.
21. Rosenbaum MB, Blanco HH, Elizari MV, Lazzari JO, Davidenko JM. Electrotonic modulation of the T wave and cardiac memory. Am J Cardiol. 50:1982;213-222.
22. Rosenbaum MB, Blanco HH, Elizari MV. Electrocardiographic characteristics and main causes of pseudoprimary T wave changes. Coumel P, Garfein OB. Electrocardiography: Past and Future. 1990;36-50.
23. Shvilkin A, Danilo P Jr, Wang J. Evolution and resolution of long-term cardiac memory. Circulation. 97:1998;1810-1817.
24. Rosen MR, Cohen IS, Danilo P Jr, Steinberg SF. The heart remembers. Cardiovasc Res. 40:1998;469-482.
25. Yu H, McKinnon D, Dixon JE. Transient outward current, Ito1, is altered in cardiac memory. Circulation. 99:1999;1898-1905.
26. Katz AM. T wave 'memory': Possible causal relationship to stress-induced changes in cardiac ion channels? J Cardiovasc Electrophysiol. 3:1992;150-159.
27. Ricard P, Danilo P Jr, Cohen IS, Burkhoff D, Rosen MR. A role for therenin-angiotensin system in the evolution of cardiac memory. J Cardiovasc Electrophysiol. 10:1999;545-551.
28. Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation. 85:1992;1046-1055.
29. Myerburg RJ, Epstein K, Gaide MS. Electrophysiologic consequences of experimental acute ischemia superimposed on healed myocardial infarction in cats. Am J Cardiol. 49:1982;323-330.
30. Peters NS, Wit AL. Myocardial architecture and ventricular arrhythmogenesis. Circulation. 97:1998;1746-1754.
31. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet. 343:1994;327-329.
32. Murray A, McLaughlin NB, Bourke JP, Doig JC, Furniss SS, Campbell RW. Errors in manual measurement of QT intervals. Br Heart J. 71:1994;386-390.
33. Murray A, McLaughlin NB, Campbell RW. Measuring QT dispersion: man versus machine. Heart. 77:1997;539-542.
34. Fu GS, Meissner A, Simon R. Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function. Eur Heart J. 18:1997;281-289.
35. Lindsay SJ, Brooksby P, Batin PD. The addition of late potentials and QT measurements to heart rate variability analysis does not improve risk stratification in chronic heart failure (Abstr). Circulation. 98:1998;I-440.
36. Morley-Davies A, Cobbe SM, Dargie HJ. Non-invasive prediction of death in chronic heart failure (Abstr). Heart. 81:1999;7P.
37. Coumel P. Safety of bepridil: from review of the European data. Am J Cardiol. 69:1992;75D-78D.
38. Simons FER, Kesselmann MS, Giddings NG, Pelech AN, Simons KJ. Astemizole-induced torsades de pointes. Lancet. 45:1988;624.
39. Woosley RL, Chen Y, Freiman JP, Gilles RA. Mechanism of the cardiotoxic actions terfenadine. JAMA. 269:1993;1532-1536.
40. Gitler B, Berger LS, Buffa SD. Torsades de pointes induced by erythromycin. Chest. 105:1994;368-372.
41. White NJ, Looareesuwan S, Warrell DA. Quinine and quinidine: a comparison of EKG effects during the treatment of malaria. J Cardiovasc Pharmacol. 5:1983;173-175.
42. Nosten F, ter Kuile FO, Luxemburger C. Cardiac effects of antimalarial treatment with halofantrine. Lancet. 341:1993;1054-1056.
43. Honig PK, Wortham DC, Zamani K, Conner DP, Mulin JC, Cantilena LR. Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences. JAMA. 269:1993;1513-1518.
44. Baker B, Dorian P, Sandor P, Shapiro C, Mitchell J, Irvine MJ. Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorders. J Clin Psychopharmacol. 17:1997;15-21.
45. Swanson JR, Jones GR, Krasselt W, Denmark LN, Ratti F. Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: a review of the literature and possible mechanisms. J Forensic Sci. 42:1997;335-339.
46. Buckley NA, Whyte IM, Dawson AH. Cardiotoxicity more common in thioridazine overdose than with other neuroleptics. J Toxicol Clin Toxicol. 33:1995;199-204.
47. Barnett AA. Safety concerns over antipsychotic drug, sertindole. Lancet. 348:1996;256.
48. Current Problems in Pharmacovigilance. 21:1995;1.
49. Wysowski DK, Bacsanyi J. Cisapride and fatal arrhythmia. N Engl J Med. 335:1996;290-291.
50. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. 270:1993;2590-2597.